For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid ...

For the study, researchers recruited 73 people with rare and inherited genetic mutations that cause the overproduction of a protein called amyloid in the brain. In case you’re not familiar ...

The findings suggest -- for the first time in a clinical trial -- that early treatment to remove amyloid plaques from the brain many years before symptoms arise can delay the onset of Alzheimer's ...

This mechanism, which involves extracellular accumulation of a 56 kDa soluble amyloid-β (Aβ ... rather than permanent neuropathological, brain alterations. Lesné et al. propose that the ...

Inert amyloid fibrils of the Alzheimer's Aβ-peptide 1–42 (Aβ 42) were incubated overnight with liposomes and various lipids including cholesterol, sphingolipids, gangliosides and brain extract.

Both Kisunla and Leqembi are laboratory-made antibodies, administered by IV, that target one contributor to Alzheimer’s — sticky amyloid plaque buildup in the brain. Questions remain about which ...

An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function.

Both early-onset and late-onset Alzheimer's disease start with amyloid slowly collecting in the brain two decades before memory and thinking problems arise. Further, all trial results from these ...